naltrexone has been researched along with ro 64-6198 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakalkin, G; Kreek, MJ; Kuzmin, A; Liljequist, S | 1 |
Fantegrossi, WE; Galuska, CM; Ko, MC; Prinssen, EP; Wichmann, J; Woods, JH | 1 |
Lindsey, AM; Prinssen, EP; Rice, KC; Saccone, PA; Sulima, A; Wichmann, J; Woods, JH; Zelenock, KA | 1 |
3 other study(ies) available for naltrexone and ro 64-6198
Article | Year |
---|---|
The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
Topics: Alcohol Drinking; Alcohols; Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Imidazoles; Male; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Rats; Rats, Wistar; Receptors, Opioid; Saccharin; Self Administration; Spiro Compounds; Sweetening Agents | 2007 |
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Topics: Alfentanil; Analgesics, Opioid; Animals; Behavior, Animal; Benzimidazoles; Capsaicin; Central Nervous System Agents; Dose-Response Relationship, Drug; Female; Hot Temperature; Imidazoles; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Pain; Piperidines; Pruritus; Receptors, Opioid; Receptors, Opioid, mu; Reinforcement, Psychology; Respiratory Insufficiency; Spiro Compounds | 2009 |
Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.
Topics: Analgesics, Opioid; Animals; Benzimidazoles; Conditioning, Operant; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Fentanyl; GABA Modulators; Imidazoles; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Pain Measurement; Piperidines; Receptors, Opioid; Spiro Compounds | 2016 |